PCG
80
3
C
60
-2
BIIB
37
7
ADP
69
-3
AEE
61
3
LEN
55
-9
IVZ
50
-3
TXT
58
-2
CHD
54
6
HCP
64
-2
LNC
52
2
KSS
39
6
EMC
53
-3
WU
12
-4
UNH
53
-3
INTU
63
-2
L
55
-4
LEG
27
-2
DHI
53
-3
MU
34
3
PCG
80
3
C
60
-2
BIIB
37
7
ADP
69
-3
AEE
61
3
LEN
55
-9
IVZ
50
-3
TXT
58
-2
CHD
54
6
HCP
64
-2
LNC
52
2
KSS
39
6
EMC
53
-3
WU
12
-4
UNH
53
-3
INTU
63
-2
L
55
-4
LEG
27
-2
DHI
53
-3
MU
34
3
Financhill
Back

Kratos Defense & Security Solutions Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
64

KTOS
Kratos Defense & Security Solutions

Last Price:
22.90
Seasonality Move:
-3.37%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Buy
64
Kratos Defense & Security Solutions (KTOS) is a Buy

Is Kratos Defense & Security Solutions a Buy, Sell or Hold?

  • The current Kratos Defense & Security Solutions [KTOS] share price is $22.91. The Score for KTOS is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • KTOS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

KTOS Stock Price Chart

What is Kratos Defense & Security Solutions's stock price today?

  • The Kratos Defense & Security Solutions share price today is $22.91
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KTOS is experiencing slight selling pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

KTOS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.38 Buy
Relative Strength Index (14 RSI): 58.73 Buy
Chaikin Money Flow: -491463 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.33 - 22.73) Buy
Bollinger Bands (100): (19.81 - 22.13) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

KTOS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 22.47 Buy
20-day SMA: 22.25 Buy
50-day SMA: 21.61 Buy
200-day SMA: 19.77 Buy
8-day EMA: 22.55 Buy
20-day EMA: 22.13 Buy
50-day EMA: 21.59 Buy
200-day EMA: 19.73 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Kratos Defense & Security Solutions Earnings Growth & KTOS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, an increase next quarter of $0.06 per share, an increase this year of $0.11 per share, and an increase next year of $0.12 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Kratos Defense & Security Solutions Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):